Skin cancer surgery aims to remove the tumor completely without damaging healthy tissue. But sometimes surgeons miss a few cells, leaving the disease behind. A new analysis looked at 1151 patients who had keratinocyte cancer. These patients had either 1186 lesions removed with standard surgery or with dermoscopy guidance. Dermoscopy lets doctors see the skin surface clearly before cutting. The results showed that using this visual guide reduced the rate of incomplete excision. In plain terms, fewer cancer cells were left behind when doctors used the dermoscopy tool. The data showed a strong reduction in incomplete removal across the group. This matters because leaving cells behind can lead to the cancer returning or needing more surgery. The study also looked at surgical precision and margin control. Both improved when dermoscopy was used. However, the researchers noted that all the studies were observational. This means they watched what happened without controlling every detail. There was a moderate risk of bias in the data. The evidence for squamous cell carcinoma specifically was limited. Because of these methodological constraints, the findings are not yet definitive. We need more high-quality trials to confirm how useful this tool is. Until then, this approach shows promise for improving surgical outcomes.
Systematic review and meta-analysis shows dermoscopy-guided excision reduces incomplete excision in keratinocyte cancerDermoscopy-guided cuts reduce incomplete removal of skin cancer lesions
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis examined the impact of dermoscopy-guided excision compared to conventional surgical excision on incomplete excision rates in keratinocyte cancer. The analysis included 1151 patients and 1186 lesions across multiple studies. The primary outcome measured was the incomplete excision rate, with secondary outcomes including surgical precision, recurrence outcomes, and margin control.
The pooled odds ratio for incomplete excision was 0.30, with 95% confidence intervals 0.27-0.34 and P < 0.001. This indicates a reduction in incomplete excision with the dermoscopy-guided approach. However, all included studies were observational and carried a moderate to serious risk of bias. The evidence remains limited by these methodological constraints.
Data for squamous cell carcinoma were specifically limited within the review. Serious adverse events, discontinuations, and tolerability were not reported. The authors note that evidence remains limited by methodological constraints and caution against overstatement of the evidence as definitive. Further high-quality trials are needed to confirm clinical utility and define its role in future surgical guidelines.